Impact of Citrate-stabilized superparamagnetic Iron Oxide-Nanoparticles on Head and Neck Tumor Cell Lines in Combination Therapy with ionizing Radiation (2021) Schreiber C, Franzen T, Fietkau R, Tietze R, Stein R, Friedrich B, Distel L Conference contribution Experience gained with Durvalumab Maintenance Therapy after definitive Chemoradiotherapy in Patients with NSCLC: Survival- and Toxicity Data from Routine clinical Practice (2021) Lettmaier S, Hecht M, Weissmann T, Fietkau R Conference contribution Establishment of a FACS Assay for Screening of (TEMRA) Cells in Glioblastoma Patients (2021) Scheer I, Becker I, Donaubauer AJ, Fietkau R, Gaipl U, Frey B Conference contribution High Detection Accuracy of an optimized 3D Convolutional Neural Network for Auto Detection and Auto Segmentation of Brain Metastases (2021) Putz F, Weissmann T, Mansoorian S, Schmitter C, Semrau S, Lettmaier S, Masitho S, et al. Conference contribution Implementation of Whole Skin Therapy: Dosimetry, Optimization and FMEA Analysis (2021) Shariff M, Lotter M, Stillkrieg W, Bert C Conference contribution Low-dose Radiotherapy is highly effective in the Treatment of Patients with painful Ankle Arthrosis (2021) Weissmann T, Putz F, Hecht M, Zhou J, Donaubauer AJ, Fietkau R, Gaipl U, et al. Conference contribution Shifts in Macrophage as a prognostic Biomarker in Patients with luminal Breast Cancer - A Confirmatory Study (2021) Schnellhardt S, Segelhorst S, Erber R, Daniel C, Hartmann A, Fasching P, Beckmann M, et al. Conference contribution New, mobile CBCT-System (ImagingRing m) for image-guided Brachytherapy - Quality Assurance (2021) Karius A, Strnad V, Bert C Conference contribution 12 x 6 Gy stereotactic radiotherapy for lung tumours. Is there a difference in response between lung metastases and primary bronchial carcinoma? (2021) Lubgan D, Semrau S, Lambrecht U, Gaipl U, Fietkau R Conference contribution Prospective Assessment of the Inflammation Parameters in Blood Counts and Blood Serum as prognostic/predictive Parameters for Treatment with Immune Checkpoint-Inhibitors (2021) Schweizer C, Haderlein M, Schubert P, Zhou J, Semrau S, Rutzner S, Gostian AO, et al. Conference contribution